BioMarin Pharmaceutical logo (PRNewsfoto/BioMarin Pharmaceutical ... The BioMarin patent was confirmed by the European Patent Office's Opposition Division in 2024. "Intellectual property provides ...

Once a patent is granted by the European Patent Office (EPO), the applicant will have the option to individually validate in desired European Patent Convention (EPC) states (i.e., the traditional ...

FRANKFURT, Nov 21 (Reuters) - The European Patent Office declared a contested mRNA patent owned by Moderna (MRNA.O), opens new tab invalid, the office said on Tuesday, handing a win to BioNTech ...

To understand the impact, this article provides a background on how the European Patent Office (EPO) and UPC consider earlier national rights, how patent applicants can address earlier national ...